NDC 69152-1015

Cantharis 200C

Cantharis

Cantharis 200C is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Paramesh Banerji Life Sciences Llc. The primary component is Lytta Vesicatoria.

Product ID69152-1015_2f2e2220-6fca-0e0a-e054-00144ff8d46c
NDC69152-1015
Product TypeHuman Otc Drug
Proprietary NameCantharis 200C
Generic NameCantharis
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-05-21
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameParamesh Banerji Life Sciences LLC
Substance NameLYTTA VESICATORIA
Active Ingredient Strength200 [hp_C]/1
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 69152-1015-1

96 PELLET in 1 BOTTLE (69152-1015-1)
Marketing Start Date2015-05-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69152-1015-1 [69152101501]

Cantharis 200C PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-05-21
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LYTTA VESICATORIA200 [hp_C]/1

OpenFDA Data

SPL SET ID:169508a6-4dc9-39f5-e054-00144ff88e88
Manufacturer
UNII

NDC Crossover Matching brand name "Cantharis 200C" or generic name "Cantharis"

NDCBrand NameGeneric Name
69152-1015Cantharis 200CCantharis
0360-0093CANTHARISCANTHARIS
0360-0094CANTHARISCANTHARIS
15631-0105CANTHARISCANTHARIS
15631-0552CANTHARISCANTHARIS
15631-2311CANTHARISCANTHARIS
53645-1660CantharisCantharis
60512-9151CANTHARISCANTHARIS
63083-7111CantharisCantharis
69152-1213Cantharis 6CCantharis

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.